| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 28.459 | 71.836 | 135.744 |
| Total Income - EUR | - | - | - | - | - | - | - | 28.459 | 71.836 | 135.744 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 6.380 | 14.450 | 11.651 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 22.079 | 57.385 | 124.092 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 21.243 | 56.775 | 120.102 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 1 |
Check the financial reports for the company - Femme-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | - | 21.801 | 58.997 | 124.885 |
| Inventories | - | - | - | - | - | - | - | 234 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 51 | 26.880 | 113.669 |
| Cash | - | - | - | - | - | - | - | 21.517 | 32.117 | 11.216 |
| Shareholders Funds | - | - | - | - | - | - | - | 21.283 | 58.185 | 120.150 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 518 | 812 | 4.735 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Femme-Med S.r.l.